Hemoglobin Oxygen Therapeutics LLC (HOTI)

Hemoglobin Oxygen Therapeutics LLC will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Chart not available yet
Data will show when the stock starts trading.
Market Capn/a
Revenue (ttm)n/a
Net Income (ttm)-6.13M
Shares Outn/a
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Openn/a
Previous Closen/a
Day's Rangen/a
52-Week Rangen/a
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About HOTI

Hemoglobin Oxygen Therapeutics is a biotechnology company focused on the development, manufacture, and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. Using our patents, proprietary technology and know-how, we develop and sell products that, under certain conditions, are a possible alternative to blood transfusions to deliver oxygen to organs and tissues. Through numerous clinical studies, our products have been shown to address...

IndustryHealth Care
Founded2014
CEOZafiris G. Zafirelis
Employees10
Stock ExchangeNASDAQ
Ticker SymbolHOTI
Full Company Profile

Financial Performance

Financial Statements

News

Hemoglobin Oxygen Therapeutics IPO Registration Document (S-1)

Hemoglobin Oxygen Therapeutics has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC